22.05.2017 • News

IMCD Buys Bossco Industries

(c) Goodluz/Shutterstock
(c) Goodluz/Shutterstock

Dutch specialty chemicals distributor IMCD has purchased Bossco Industries in the US for an undisclosed sum. Located in Houston, Texas, Bossco supplies products and technical solutions to all major industrial market segments in the country’s southwestern region. The company generated revenues of $11 million in 2016.

After the transaction is completed, which is expected in early July 2017, the business will be integrated within IMCD US with Bossco’s president Edward Boss becoming a senior member of the IMCD management team.

John Mastrantoni, president of IMCD US, said the acquisition further strengthens the US business and its ability to offer national coverage to its principal partners.

Last month, IMCD opened its first application laboratory in the country. The facility in Miami, Florida, will service customers and suppliers in the personal care segment, offering advice on market trends as well as problem solving, formulation guidance and product performance testing. “We see this as the first step towards replicating the successful technical center model we have established in other regions,” said Marcus Jordan, president of IMCD US Holdings.

In March, the Rotterdam-based group completed the purchase of the remaining 20% interest in M.F. Cachat, an Ohio-based specialty chemical distributor. The acquisition was executed on the basis of the share purchase agreement made in June 2015 when IMCD bought an 80% stake. M.F. Cachat was renamed IMCD US on Apr. 1, 2016.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.